• Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Moderate Buy" by Analysts

    来源: Buzz FX / 06 11月 2024 02:36:17   America/Chicago


    Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Moderate Buy" by Analysts Written by MarketBeat November 6, 2024 Share Link copied to clipboard. Enanta Pharmaceuticals, Inc. ( NASDAQ:ENTA - Get Free Report ) has been g
    Read more...
分享